|
|
Blood, 15 May 2008, Vol. 111, No. 10, pp. 4892-4901.
Prepublished online as a Blood First Edition Paper on March 12, 2008; DOI 10.1182/blood-2007-11-125039.
Previous Article | Next Article 
Submitted November 26, 2007
Accepted February 20, 2008
CCL5-mediated T cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1
Thomas T Murooka, Ramtin Rahbar, Leonidas C Platanias, and Eleanor N Fish*
Division of Cellular and Molecular Biology, Toronto General Research Institute, UHN & Department of Immunology, University of Toronto, Toronto, Canada
Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, IL, United States
* Corresponding author; email: en.fish{at}utoronto.ca.
The multi-step, coordinated process of T cell chemotaxis requires chemokines, and their chemokine receptors, to invoke signaling events to direct cell migration. Here, we examined the role for CCL5-mediated initiation of mRNA translation in CD4+ T cell chemotaxis. Using rapamycin, an inhibitor of mTOR, our data show the importance of mTOR in CCL5-mediated T cell migration. Cycloheximide, but not actinomycin D, significantly reduced chemotaxis, suggesting a possible role for mRNA translation in T cell migration. CCL5 induced phosphorylation/activation of mTOR, p70 S6K1 and ribosomal protein S6. Additionally, CCL5 induced PI-3'K-, phospholipase D (PLD)- and mTOR-dependent phosphorylation and deactivation of the transcriptional repressor 4E-BP1, which resulted in its dissociation from the eukaryotic initiation factor-4E (eIF4E). Subsequently, eIF4E associated with scaffold protein eIF4G, forming the eIF4F translation initiation complex. Indeed, CCL5 initiated active translation of mRNA, shown by the increased presence of high-molecular-weight polysomes which were significantly reduced by rapamycin treatment. Notably, CCL5 induced protein translation of cyclin D1 and MMP-9, known mediators of migration. Taken together, we describe a novel mechanism by which CCL5 influences translation of rapamycin-sensitive mRNAs and "primes" CD4+ T cell for efficient chemotaxis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. J. Pappas, G. Coppola, P. A. Gabatto, F. Gao, D. H. Geschwind, J. R. Oksenberg, and S. E. Baranzini
Longitudinal system-based analysis of transcriptional responses to type I interferons
Physiol Genomics,
August 7, 2009;
38(3):
362 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Baetta, A. Granata, M. Canavesi, N. Ferri, L. Arnaboldi, S. Bellosta, P. Pfister, and A. Corsini
Everolimus Inhibits Monocyte/Macrophage Migration in Vitro and Their Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits
J. Pharmacol. Exp. Ther.,
February 1, 2009;
328(2):
419 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B.K. Schwarz, N. Langwieser, N. N. Langwieser, M. J. Bek, S. Seidl, H.-H. Eckstein, B. Lu, A. Schomig, H. Pavenstadt, and D. Zohlnhofer
Novel Role of the CXC Chemokine Receptor 3 in Inflammatory Response to Arterial Injury: Involvement of mTORC1
Circ. Res.,
January 30, 2009;
104(2):
189 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|